Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Size-induced segregation during die filling.

Zakhvatayeva A, Hare C, Wu CY.

Int J Pharm X. 2019 Aug 19;1:100032. doi: 10.1016/j.ijpx.2019.100032. eCollection 2019 Dec.

2.

Implementing electronic substance use disorder and depression and anxiety screening and behavioral interventions in primary care clinics serving people with HIV: Protocol for the Promoting Access to Care Engagement (PACE) trial.

Satre DD, Anderson AN, Leibowitz AS, Levine-Hall T, Slome S, Flamm J, Hare CB, McNeely J, Weisner CM, Horberg MA, Volberding P, Silverberg MJ.

Contemp Clin Trials. 2019 Sep;84:105833. doi: 10.1016/j.cct.2019.105833. Epub 2019 Aug 22.

PMID:
31446142
3.

Alcohol and drug use, partner PrEP use and STI prevalence among people with HIV.

Hojilla JC, Marcus J, Volk JE, Leyden W, Hare CB, Hechter RC, Edelman EJ, Silverberg M, Satre DD.

Sex Transm Infect. 2019 Aug 23. pii: sextrans-2019-054049. doi: 10.1136/sextrans-2019-054049. [Epub ahead of print]

PMID:
31444278
4.

Patient-physician relationships, health self-efficacy, and gynecologic cancer screening among women with Lynch syndrome.

McGarragle KM, Aronson M, Semotiuk K, Holter S, Hare CJ, Ferguson SE, Cohen Z, Hart TL.

Hered Cancer Clin Pract. 2019 Aug 13;17:24. doi: 10.1186/s13053-019-0123-7. eCollection 2019.

5.

Preliminary evaluation of a salivary urea test strip method for use in dogs.

Sanchini L, Hare CHZ, Restif O, Williams TL.

Vet Clin Pathol. 2019 Sep;48(3):413-418. doi: 10.1111/vcp.12765. Epub 2019 Aug 10.

PMID:
31401808
6.

Examining intrafamilial communication of colorectal cancer risk status to family members and kin responses to colonoscopy: a qualitative study.

McGarragle KM, Hare C, Holter S, Facey DA, McShane K, Gallinger S, Hart TL.

Hered Cancer Clin Pract. 2019 Jun 26;17:16. doi: 10.1186/s13053-019-0114-8. eCollection 2019.

7.

Interventions to Reduce Unhealthy Alcohol Use among Primary Care Patients with HIV: the Health and Motivation Randomized Clinical Trial.

Satre DD, Leibowitz AS, Leyden W, Catz SL, Hare CB, Jang H, Lam JO, Bryant KJ, Weisner CM, Sterling SA, Horberg M, Volberding P, Silverberg MJ.

J Gen Intern Med. 2019 Jun 11. doi: 10.1007/s11606-019-05065-9. [Epub ahead of print]

PMID:
31187344
8.

Rapid in-house method of CSF analysis utilising sedimentation direct from the spinal needle.

Hare C, Sanchini L, Worrall C, Van Poucke S, Alves L, Restif O, Freeman P.

J Small Anim Pract. 2019 Aug;60(8):486-492. doi: 10.1111/jsap.13010. Epub 2019 Apr 26.

PMID:
31025384
9.

Prevalence of Spontaneous Clearance of Hepatitis C Virus Infection Doubled From 1998 to 2017.

Seo S, Silverberg MJ, Hurley LB, Ready J, Saxena V, Witt D, Hare CB, Champsi JH, Korn DG, Pauly MP, Chamberland S, Lai JB, Marcus JL.

Clin Gastroenterol Hepatol. 2019 Apr 19. pii: S1542-3565(19)30425-2. doi: 10.1016/j.cgh.2019.04.035. [Epub ahead of print]

PMID:
31009792
10.

Adverse childhood experiences, mental health, substance use, and HIV-related outcomes among persons with HIV.

Young-Wolff KC, Sarovar V, Sterling SA, Leibowitz A, McCaw B, Hare CB, Silverberg MJ, Satre DD.

AIDS Care. 2019 Oct;31(10):1241-1249. doi: 10.1080/09540121.2019.1587372. Epub 2019 Mar 19.

PMID:
30887831
11.

Myoclonus and hypercalcemia in a dog with poorly differentiated lymphoproliferative neoplasia.

Hare CHZ, Archer J, Cloup E, Genain MA, Hughes K, McCallum KE, Alves L.

J Vet Intern Med. 2019 Mar;33(2):856-861. doi: 10.1111/jvim.15398. Epub 2018 Dec 18.

12.

An experimental study of die filling of pharmaceutical powders using a rotary die filling system.

Zakhvatayeva A, Zhong W, Makroo HA, Hare C, Wu CY.

Int J Pharm. 2018 Dec 20;553(1-2):84-96. doi: 10.1016/j.ijpharm.2018.09.067. Epub 2018 Oct 12.

PMID:
30321642
13.

Psychological symptoms and perceived cognitive impairment in multiple sclerosis: The role of rumination.

Malivoire BL, Hare CJ, Hart TL.

Rehabil Psychol. 2018 May;63(2):286-294. doi: 10.1037/rep0000180.

PMID:
29878833
14.

Factors associated with hazardous alcohol use and motivation to reduce drinking among HIV primary care patients: Baseline findings from the Health & Motivation study.

Silverberg MJ, Leyden WA, Leibowitz A, Hare CB, Jang HJ, Sterling S, Catz SL, Parthasarathy S, Horberg MA, Satre DD.

Addict Behav. 2018 Sep;84:110-117. doi: 10.1016/j.addbeh.2018.03.033. Epub 2018 Mar 31.

15.

Autism BrainNet: A network of postmortem brain banks established to facilitate autism research.

Amaral DG, Anderson MP, Ansorge O, Chance S, Hare C, Hof PR, Miller M, Nagakura I, Pickett J, Schumann C, Tamminga C.

Handb Clin Neurol. 2018;150:31-39. doi: 10.1016/B978-0-444-63639-3.00003-7. Review.

PMID:
29496150
16.

HIV Infection and Drug Resistance with Unsupervised Use of HIV Pre-Exposure Prophylaxis.

Volk JE, Nguyen DP, Hare CB, Marcus JL.

AIDS Res Hum Retroviruses. 2018 Apr;34(4):329-330. doi: 10.1089/AID.2017.0285. Epub 2018 Jan 18.

17.

Impact breakage of pharmaceutical tablets.

Hare C, Bonakdar T, Ghadiri M, Strong J.

Int J Pharm. 2018 Jan 30;536(1):370-376. doi: 10.1016/j.ijpharm.2017.11.066. Epub 2017 Dec 22.

18.

A Pharmacist-Led Program to Evaluate and Reduce Polypharmacy and Potentially Inappropriate Prescribing in Older HIV-Positive Patients.

McNicholl IR, Gandhi M, Hare CB, Greene M, Pierluissi E.

Pharmacotherapy. 2017 Dec;37(12):1498-1506. doi: 10.1002/phar.2043. Epub 2017 Nov 30.

PMID:
29023938
19.

Insomnia Symptoms, Subjective Appraisals, and Fatigue: A Multiple Mediation Model.

Hare CJ, Crangle CJ, Carney CE, Hart T.

Behav Sleep Med. 2019 May-Jun;17(3):269-280. doi: 10.1080/15402002.2017.1342167. Epub 2017 Jul 17.

PMID:
28609122
20.

Cutaneous afferent feedback from the posterior ankle contributes to proprioception.

Mildren RL, Hare CM, Bent LR.

Neurosci Lett. 2017 Jan 1;636:145-150. doi: 10.1016/j.neulet.2016.10.058. Epub 2016 Oct 29.

PMID:
27984196
21.

Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation.

Marcus JL, Hurley LB, Hare CB, Nguyen DP, Phengrasamy T, Silverberg MJ, Stoltey JE, Volk JE.

J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):540-546.

22.

Risk and radical uncertainty in HIV research.

Hare C.

J Med Ethics. 2017 Feb;43(2):87-89. doi: 10.1136/medethics-2015-103117. Epub 2016 Sep 26.

23.

Disparities in Uptake of HIV Preexposure Prophylaxis in a Large Integrated Health Care System.

Marcus JL, Hurley LB, Hare CB, Silverberg MJ, Volk JE.

Am J Public Health. 2016 Oct;106(10):e2-3. doi: 10.2105/AJPH.2016.303339. No abstract available.

24.

Mind Over Matter? The Hidden Epidemic of Cognitive Dysfunction in the Older Surgical Patient.

O' Brien H, Mohan H, Hare CO, Reynolds JV, Kenny RA.

Ann Surg. 2017 Apr;265(4):677-691. doi: 10.1097/SLA.0000000000001900. Review.

PMID:
27537541
25.

Rapid Growth of Crystalline Mn5O8 by Self-Limited Multilayer Deposition using Mn(EtCp)2 and O3.

Young MJ, Hare CD, Cavanagh AS, Musgrave CB, George SM.

ACS Appl Mater Interfaces. 2016 Jul 20;8(28):18560-9. doi: 10.1021/acsami.6b04529. Epub 2016 Jul 11.

PMID:
27351207
26.
27.

Geriatric Assessments and Association With VACS Index Among HIV-Infected Older Adults in San Francisco.

John MD, Greene M, Hessol NA, Zepf R, Parrott AH, Foreman C, Bourgeois J, Gandhi M, Hare CB.

J Acquir Immune Defic Syndr. 2016 Aug 15;72(5):534-41. doi: 10.1097/QAI.0000000000001009.

28.

Successful Implementation of HIV Preexposure Prophylaxis: Lessons Learned From Three Clinical Settings.

Marcus JL, Volk JE, Pinder J, Liu AY, Bacon O, Hare CB, Cohen SE.

Curr HIV/AIDS Rep. 2016 Apr;13(2):116-24. doi: 10.1007/s11904-016-0308-x. Review.

PMID:
26898645
29.

No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting.

Volk JE, Marcus JL, Phengrasamy T, Blechinger D, Nguyen DP, Follansbee S, Hare CB.

Clin Infect Dis. 2015 Nov 15;61(10):1601-3. doi: 10.1093/cid/civ778. Epub 2015 Sep 1.

30.

Incident Hepatitis C Virus Infections Among Users of HIV Preexposure Prophylaxis in a Clinical Practice Setting.

Volk JE, Marcus JL, Phengrasamy T, Hare CB.

Clin Infect Dis. 2015 Jun 1;60(11):1728-9. doi: 10.1093/cid/civ129. Epub 2015 Feb 18. No abstract available.

31.

Dual-mode optical sensing of organic vapors and proteins with polydiacetylene (PDA)-embedded electrospun nanofibers.

Davis BW, Burris AJ, Niamnont N, Hare CD, Chen CY, Sukwattanasinitt M, Cheng Q.

Langmuir. 2014 Aug 12;30(31):9616-22. doi: 10.1021/la5017388. Epub 2014 Jul 28.

PMID:
25025399
32.

Effect of soil moisture on chlorine deposition.

Hearn J, Eichler J, Hare C, Henley M.

J Hazard Mater. 2014 Feb 28;267:81-7. doi: 10.1016/j.jhazmat.2013.12.044. Epub 2013 Dec 27.

PMID:
24434132
33.

Patient perspectives on the experience of being newly diagnosed with HIV in the emergency department/urgent care clinic of a public hospital.

Christopoulos KA, Massey AD, Lopez AM, Hare CB, Johnson MO, Pilcher CD, Fielding H, Dawson-Rose C.

PLoS One. 2013 Aug 26;8(8):e74199. doi: 10.1371/journal.pone.0074199. eCollection 2013.

34.

Wastewater polishing by a channelized macrophyte-dominated wetland and anaerobic digestion of the harvested phytomass.

Cohen MF, Hare C, Kozlowski J, McCormick RS, Chen L, Schneider L, Parish M, Knight Z, Nelson TA, Grewell BJ.

J Environ Sci Health A Tox Hazard Subst Environ Eng. 2013;48(3):319-30. doi: 10.1080/10934529.2013.726896.

PMID:
23245307
35.

Leveraging a rapid, round-the-clock HIV testing system to screen for acute HIV infection in a large urban public medical center.

Christopoulos KA, Zetola NM, Klausner JD, Haller B, Louie B, Hare CB, Pandori M, Nassos P, Roemer M, Pilcher CD.

J Acquir Immune Defic Syndr. 2013 Feb 1;62(2):e30-8. doi: 10.1097/QAI.0b013e31827a0b0d.

36.

Cl2 deposition on soil matrices.

Hearn J, Eichler J, Hare C, Henley M.

J Hazard Mater. 2012 Oct 30;237-238:307-14. doi: 10.1016/j.jhazmat.2012.08.046. Epub 2012 Aug 24.

PMID:
22975257
37.

The effect of a "universal antiretroviral therapy" recommendation on HIV RNA levels among HIV-infected patients entering care with a CD4 count greater than 500/μL in a public health setting.

Geng EH, Hare CB, Kahn JO, Jain V, Van Nunnery T, Christopoulos KA, Deeks SG, Gandhi M, Havlir DV.

Clin Infect Dis. 2012 Dec;55(12):1690-7. doi: 10.1093/cid/cis750. Epub 2012 Sep 5.

38.

Low rates of hepatitis screening and vaccination of HIV-infected MSM in HIV clinics.

Hoover KW, Butler M, Workowski KA, Follansbee S, Gratzer B, Hare CB, Johnston B, Theodore JL, Tao G, Smith BD, Chorba T, Kent CK; Evaluation Group for Adherence to STD and Hepatitis Screening.

Sex Transm Dis. 2012 May;39(5):349-53. doi: 10.1097/OLQ.0b013e318244a923.

PMID:
22504597
39.

The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals.

Hogan CM, Degruttola V, Sun X, Fiscus SA, Del Rio C, Hare CB, Markowitz M, Connick E, Macatangay B, Tashima KT, Kallungal B, Camp R, Morton T, Daar ES, Little S; A5217 Study Team.

J Infect Dis. 2012 Jan 1;205(1):87-96. doi: 10.1093/infdis/jir699. Epub 2011 Dec 15.

40.

Resistance patterns and response to entecavir intensification among HIV-HBV-coinfected adults with persistent HBV viremia.

Luetkemeyer AF, Charlebois ED, Hare CB, Black D, Smith A, Havlir DV, Peters MG.

J Acquir Immune Defic Syndr. 2011 Nov 1;58(3):e96-9. doi: 10.1097/QAI.0b013e3182303937. No abstract available.

41.

The effect of AIDS Clinical Trials Group Protocol 5164 on the time from Pneumocystis jirovecii pneumonia diagnosis to antiretroviral initiation in routine clinical practice: a case study of diffusion, dissemination, and implementation.

Geng EH, Kahn JS, Chang OC, Hare CB, Christopoulos KA, Jones D, Petersen ML, Deeks SG, Havlir DV, Gandhi M.

Clin Infect Dis. 2011 Nov;53(10):1008-14. doi: 10.1093/cid/cir608. Epub 2011 Sep 29.

42.

Cost-effectiveness of targeted human immunodeficiency virus screening in an urban emergency department.

Dowdy DW, Rodriguez RM, Hare CB, Kaplan B.

Acad Emerg Med. 2011 Jul;18(7):745-53. doi: 10.1111/j.1553-2712.2011.01110.x.

43.

Mortality among antiretroviral-eligible patients in an urban public clinic.

Dowdy DW, Geng EH, Christopoulos KA, Kahn JS, Hare CB, Wlodarczyk D, Havlir DV.

J Acquir Immune Defic Syndr. 2011 Aug 1;57(4):297-300. doi: 10.1097/QAI.0b013e31822233aa.

44.

Testing and linkage to care outcomes for a clinician-initiated rapid HIV testing program in an urban emergency department.

Christopoulos KA, Kaplan B, Dowdy D, Haller B, Nassos P, Roemer M, Dowling T, Jones D, Hare CB.

AIDS Patient Care STDS. 2011 Jul;25(7):439-44. doi: 10.1089/apc.2011.0041. Epub 2011 May 5.

45.

Modification of the Abbott RealTime assay for detection of HIV-1 plasma RNA viral loads less than one copy per milliliter.

Yukl SA, Li P, Fujimoto K, Lampiris H, Lu CM, Hare CB, Deeks SG, Liegler T, Pandori M, Havlir DV, Wong JK.

J Virol Methods. 2011 Aug;175(2):261-5. doi: 10.1016/j.jviromet.2011.04.015. Epub 2011 Apr 22.

46.

Methamphetamine use, transmission risk behavior and internet use among HIV-infected patients in medical care, San Francisco, 2008.

Clark T, Marquez C, Hare CB, John MD, Klausner JD.

AIDS Behav. 2012 Feb;16(2):396-403. doi: 10.1007/s10461-010-9869-7.

47.

Non-laxative CT colonography with barium-based faecal tagging: is additional phosphate enema beneficial and well tolerated?

Davis W, Nisbet P, Hare C, Cooke P, Taylor SA.

Br J Radiol. 2011 Feb;84(998):120-5. doi: 10.1259/bjr/23626544. Epub 2010 Oct 19.

48.

Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy.

Yukl SA, Gianella S, Sinclair E, Epling L, Li Q, Duan L, Choi AL, Girling V, Ho T, Li P, Fujimoto K, Lampiris H, Hare CB, Pandori M, Haase AT, Günthard HF, Fischer M, Shergill AK, McQuaid K, Havlir DV, Wong JK.

J Infect Dis. 2010 Nov 15;202(10):1553-61. doi: 10.1086/656722. Epub 2010 Oct 12.

49.

Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy.

Yukl SA, Shergill AK, McQuaid K, Gianella S, Lampiris H, Hare CB, Pandori M, Sinclair E, Günthard HF, Fischer M, Wong JK, Havlir DV.

AIDS. 2010 Oct 23;24(16):2451-60. doi: 10.1097/QAD.0b013e32833ef7bb.

50.

Viral hepatitis in Hawai'i--differing perspectives.

Tice AD, Bannan M, Bauman K, Collis T, Hall A, Haning W, Hannemann S, Hare CB, Humphry J, Jao R, Leevy C, Lusk H, Ochoa E, Palafox N, Withers N, Akinaka K.

Hawaii Med J. 2010 Apr;69(4 Suppl 1):3-20.

Supplemental Content

Support Center